Profil
Jeff S.
Hartness currently works at Corganics LP, as Director from 2022, Bryn Pharma LLC, as Director from 2022, and Apogee Therapeutics, Inc., as Chief Commercial Officer from 2024.
Mr. Hartness also formerly worked at Bausch Health Cos., Inc., as Executive VP-Generics and Government Affairs.
Mr. Hartness received his undergraduate degree from Hanover College.
Aktiva positioner av Jeff Hartness
| Företag | Position | Start |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Företagsledare/Principal | 2024-09-09 |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Direktör/Styrelseledamot | 2022-02-23 |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Direktör/Styrelseledamot | 2022-12-13 |
Tidigare kända positioner av Jeff Hartness
| Företag | Position | Slut |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Generell Rådgivare | - |
Jeff Hartnesss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Hanover College
Hanover College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Distribution Services |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
















